AirSculpt Technologies, Inc. Selling, General and Administrative Expense
AirSculpt Technologies, Inc. (AIRS) reported Selling, General and Administrative Expense of $23.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-10
- AirSculpt Technologies, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $23.42M, a 3.31% increase year-over-year.
- AirSculpt Technologies, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $22.58M, a 3.74% increase year-over-year.
- AirSculpt Technologies, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $18.22M, a 22.00% decline year-over-year.
- AirSculpt Technologies, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $19.52M, a 23.42% decline year-over-year.
- AirSculpt Technologies, Inc. selling, general and administrative expense for fiscal 2025 was $82.18M, a 16.89% decline from fiscal 2024.
- AirSculpt Technologies, Inc. selling, general and administrative expense for fiscal 2024 was $98.88M, a 3.42% decline from fiscal 2023.
- AirSculpt Technologies, Inc. selling, general and administrative expense for fiscal 2023 was $102.38M, a 0.95% increase from fiscal 2022.
- AirSculpt Technologies, Inc. selling, general and administrative expense for fiscal 2022 was $101.42M, a 54.29% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.42M 10-Q · filed 2026-08-10 | $46.00M 10-Q · filed 2026-08-10 | $64.22M derived: sum of 3 quarters · filed 2026-08-10 | $83.74M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $22.58M 10-Q · filed 2026-05-08 | $40.80M derived: sum of 2 quarters · filed 2026-05-08 | $60.32M derived: sum of 3 quarters · filed 2026-05-08 | $82.99M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $18.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $37.74M derived: sum of 2 quarters · filed 2026-04-06 | $60.41M derived: sum of 3 quarters · filed 2026-08-10 | $82.18M 10-K/A · filed 2026-04-06 |
| 2025-09-30 | $19.52M 10-Q · filed 2025-11-07 | $42.20M derived: sum of 2 quarters · filed 2026-08-10 | $63.96M 10-Q · filed 2025-11-07 | $87.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $22.67M 10-Q · filed 2026-08-10 | $44.44M 10-Q · filed 2026-08-10 | $67.79M derived: sum of 3 quarters · filed 2026-08-10 | $93.29M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $21.77M 10-Q · filed 2026-05-08 | $45.12M derived: sum of 2 quarters · filed 2026-05-08 | $70.62M derived: sum of 3 quarters · filed 2026-05-08 | $104.89M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $23.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $48.85M derived: sum of 2 quarters · filed 2026-04-06 | $83.12M derived: sum of 3 quarters · filed 2026-04-06 | $98.88M 10-K/A · filed 2026-04-06 |
| 2024-09-30 | $25.50M 10-Q · filed 2025-11-07 | $59.77M derived: sum of 2 quarters · filed 2025-11-07 | $75.53M 10-Q · filed 2025-11-07 | $101.10M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-06-30 | $34.27M 10-Q · filed 2025-08-01 | $50.03M 10-Q · filed 2025-08-01 | $75.61M derived: sum of 3 quarters · filed 2026-04-06 | $100.64M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-03-31 | $15.76M 10-Q · filed 2025-05-02 | $41.33M derived: sum of 2 quarters · filed 2026-04-06 | $66.36M derived: sum of 3 quarters · filed 2026-04-06 | $94.25M derived: sum of 4 quarters · filed 2026-04-06 |
| 2023-12-31 | $25.58M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $50.61M derived: sum of 2 quarters · filed 2026-04-06 | $78.50M derived: sum of 3 quarters · filed 2026-04-06 | $102.38M 10-K/A · filed 2026-04-06 |
| 2023-09-30 | $25.03M 10-Q · filed 2024-11-08 | $52.92M derived: sum of 2 quarters · filed 2024-11-08 | $76.81M 10-Q · filed 2024-11-08 | $104.65M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $27.89M 10-Q · filed 2024-08-09 | $51.77M 10-Q · filed 2024-08-09 | $79.62M derived: sum of 3 quarters · filed 2025-03-14 | $103.02M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $23.88M 10-Q · filed 2024-05-10 | $51.73M derived: sum of 2 quarters · filed 2025-03-14 | $75.12M derived: sum of 3 quarters · filed 2025-03-14 | $101.13M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $27.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $51.24M derived: sum of 2 quarters · filed 2025-03-14 | $77.25M derived: sum of 3 quarters · filed 2025-03-14 | $101.42M 10-K · filed 2025-03-14 |
| 2022-09-30 | $23.40M 10-Q · filed 2023-11-13 | $49.41M derived: sum of 2 quarters · filed 2023-11-13 | $73.57M 10-Q · filed 2023-11-13 | $108.38M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $26.01M 10-Q · filed 2023-08-11 | $50.18M 10-Q · filed 2023-08-11 | $84.98M derived: sum of 3 quarters · filed 2024-02-27 | $96.96M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $24.17M 10-Q · filed 2023-05-12 | $58.97M derived: sum of 2 quarters · filed 2024-02-27 | $70.95M derived: sum of 3 quarters · filed 2024-02-27 | $81.28M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $34.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $46.79M derived: sum of 2 quarters · filed 2024-02-27 | $57.12M derived: sum of 3 quarters · filed 2024-02-27 | $65.73M 10-K · filed 2024-02-27 |
| 2021-09-30 | $11.98M 10-Q · filed 2022-11-14 | $22.31M derived: sum of 2 quarters · filed 2022-11-14 | $30.93M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $10.33M 10-Q · filed 2022-08-12 | $18.99M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $8.66M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $23.62M 10-K · filed 2023-03-10 | |||
| 2019-12-31 | $20.13M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |